BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 28, 2005
View Archived Issues
IDO - a target for anti-HIV therapy
Read More
H-1152: superior bronchodilatory potency and suggested safety for anesthesia in asthmatics
Read More
Further evidence that TRPV1 antagonism alleviates bone cancer pain
Read More
Enrollment completed in phase IIb HCV study of Albuferon plus ribavirin
Read More
ID Biomedical updates progress of two key vaccine programs
Read More
Idera studies HYB-2055 in combination with gemcitabine and carboplatin
Read More
Encouraging results for QR-442 in multiple sclerosis mouse model
Read More
Cerimon acquires U.S. rights to topical diclofenac formulations
Read More
Bayer and Ortho-McNeil enter agreement for BAY-59-7939
Read More
AT-1001 completes phase I study, receives fast track designation
Read More
Chiron begins phase I/II study of cell culture-derived influenza vaccine
Read More
Indevus begins phase III of PRO-2000 to prevent STDs
Read More
Novelos Therapeutics to hold end-of-phase II meeting for NOV-002
Read More
Vion offers pipeline progress report
Read More
JNJ-7706621 possesses dual inhibitory activity against CDKs and Aurora kinases
Read More
Immunomodulatory agents described in Novartis patents
Read More
Novel inhibitor of sphingolipid synthesis opens a new approach for anti-HCV drug design
Read More
Recent patents disclose novel agents for the treatment of diabetes
Read More
New agents claimed for the treatment of metabolic disorders
Read More
Aptivus for HIV receives European approval
Read More
Xolair approved in Europe
Read More
Noxafil approved in E.U. for invasive fungal infections
Read More
TNX-355 reported effective in reducing viral load of HIV-infected patients
Read More
Update on pimecrolimus in the treatment of skin disorders
Read More
Studies highlight antidepressant efficacy and other benefits of agomelatine
Read More
Study reveals how adiponectin may influence survival and longevity
Read More